{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:34:24Z","timestamp":1770284064802,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03402-x","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T19:03:22Z","timestamp":1684868602000},"page":"573-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case\u2013control study"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-6296","authenticated-orcid":false,"given":"Athanasios D.","family":"Anastasilakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthaios","family":"Savvidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios A.","family":"Anastasilakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Sarridimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhanu","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polyzois","family":"Makras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"3402_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bone.2018.11.002","volume":"120","author":"L Bonewald","year":"2019","unstructured":"L. Bonewald, Use it or lose it to age: a review of bone and muscle communication. Bone 120, 212\u2013218 (2019). https:\/\/doi.org\/10.1016\/j.bone.2018.11.002","journal-title":"Bone"},{"issue":"2","key":"3402_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.exger.2012.11.004","volume":"48","author":"M Bowser","year":"2013","unstructured":"M. Bowser, S. Herberg, P. Arounleut, X. Shi, S. Fulzele, W.D. Hill, C.M. Isales, M.W. Hamrick, Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells. Exp. Gerontol. 48(2), 290\u2013297 (2013). https:\/\/doi.org\/10.1016\/j.exger.2012.11.004","journal-title":"Exp. Gerontol."},{"key":"3402_CR3","doi-asserted-by":"publisher","first-page":"155397","DOI":"10.1016\/j.metabol.2022.155397","volume":"141","author":"AD Anastasilakis","year":"2022","unstructured":"A.D. Anastasilakis, S.A. Polyzos, N.E. Rodopaios, P. Makras, A. Kumar, B. Kalra, C.S. Mantzoros, Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study. Metabolism 141, 155397 (2022). https:\/\/doi.org\/10.1016\/j.metabol.2022.155397","journal-title":"Metabolism"},{"issue":"3","key":"3402_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s12020-021-02738-6","volume":"73","author":"AD Anastasilakis","year":"2021","unstructured":"A.D. Anastasilakis, S.A. Polyzos, D. Kitridis, P. Makras, M.P. Yavropoulou, A. Palermo, S. Gerou, C. Ntenti, I. Ballaouri, M. Savvidis, \u0399risin levels in postmenopausal women with an incident hip fracture. Endocrine 73(3), 719\u2013722 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02738-6","journal-title":"Endocrine"},{"issue":"5","key":"3402_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/bf00299321","volume":"55","author":"S Inoue","year":"1994","unstructured":"S. Inoue, S. Nomura, T. Hosoi, Y. Ouchi, H. Orimo, M. Muramatsu, Localization of follistatin, an activin-binding protein, in bone tissues. Calcif. Tissue Int. 55(5), 395\u2013397 (1994). https:\/\/doi.org\/10.1007\/bf00299321","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"3402_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1359\/jbmr.1997.12.3.403","volume":"12","author":"T Shuto","year":"1997","unstructured":"T. Shuto, G. Sarkar, J.T. Bronk, N. Matsui, M.E. Bolander, Osteoblasts express types I and II activin receptors during early intramembranous and endochondral bone formation. J. Bone Min. Res. 12(3), 403\u2013411 (1997). https:\/\/doi.org\/10.1359\/jbmr.1997.12.3.403","journal-title":"J. Bone Min. Res."},{"issue":"3","key":"3402_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/jor.1100160307","volume":"16","author":"T Nagamine","year":"1998","unstructured":"T. Nagamine, T. Imamura, Y. Ishidou, M. Kato, F. Murata, P. ten Dijke, T. Sakou, Immunohistochemical detection of activin A, follistatin, and activin receptors during fracture healing in the rat. J. Orthop. Res. 16(3), 314\u2013321 (1998). https:\/\/doi.org\/10.1002\/jor.1100160307","journal-title":"J. Orthop. Res."},{"issue":"12","key":"3402_CR8","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1007\/s11999-009-0981-9","volume":"467","author":"M Fajardo","year":"2009","unstructured":"M. Fajardo, C.J. Liu, K. Egol, Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study. Clin. Orthop. Relat. Res. 467(12), 3071\u20133078 (2009). https:\/\/doi.org\/10.1007\/s11999-009-0981-9","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"2","key":"3402_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s8756-3282(99)00152-0","volume":"25","author":"R Sakai","year":"1999","unstructured":"R. Sakai, K. Miwa, Y. Eto, Local administration of activin promotes fracture healing in the rat fibula fracture model. Bone 25(2), 191\u2013196 (1999). https:\/\/doi.org\/10.1016\/s8756-3282(99)00152-0","journal-title":"Bone"},{"issue":"2","key":"3402_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/jor.22985","volume":"34","author":"A Morse","year":"2016","unstructured":"A. Morse, T.L. Cheng, L. Peacock, K. Mikulec, D.G. Little, A. Schindeler, RAP-011 augments callus formation in closed fractures in rats. J. Orthop. Res. 34(2), 320\u2013330 (2016). https:\/\/doi.org\/10.1002\/jor.22985","journal-title":"J. Orthop. Res."},{"issue":"9","key":"3402_CR11","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/jbmr.2238","volume":"29","author":"BH Yoon","year":"2014","unstructured":"B.H. Yoon, L. Esquivies, C. Ahn, P.C. Gray, S.K. Ye, W. Kwiatkowski, S. Choe, An activin A\/BMP2 chimera, AB204, displays bone-healing properties superior to those of BMP2. J. Bone Min. Res. 29(9), 1950\u20131959 (2014). https:\/\/doi.org\/10.1002\/jbmr.2238","journal-title":"J. Bone Min. Res."},{"issue":"3","key":"3402_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00223-016-0148-0","volume":"99","author":"LB Tank\u00f3","year":"2016","unstructured":"L.B. Tank\u00f3, J. Goldhahn, A. Varela, E. Lesage, S.Y. Smith, A. Pilling, S. Chivers, Does activin receptor blockade by bimagrumab (BYM338) pose detrimental effects on bone healing in a rat fibula osteotomy model. Calcif. Tissue Int. 99(3), 310\u2013321 (2016). https:\/\/doi.org\/10.1007\/s00223-016-0148-0","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"3402_CR13","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/s2666-7568(21)00084-2","volume":"2","author":"LC Hofbauer","year":"2021","unstructured":"L.C. Hofbauer, R. Witvrouw, Z. Varga, N. Shiota, M. Cremer, L.B. Tanko, D. Rooks, L.Z. Auberson, M. Arkuszewski, N. Fretault, A.A. Schubert-Tennigkeit, D.A. Papanicolaou, C. Recknor, Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a\/b trial. Lancet Healthy Longev. 2(5), e263\u2013e274 (2021). https:\/\/doi.org\/10.1016\/s2666-7568(21)00084-2","journal-title":"Lancet Healthy Longev."},{"issue":"11","key":"3402_CR14","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1210\/me.2005-0106","volume":"19","author":"TT Wang","year":"2005","unstructured":"T.T. Wang, L.E. Tavera-Mendoza, D. Laperriere, E. Libby, N.B. MacLeod, Y. Nagai, V. Bourdeau, A. Konstorum, B. Lallemant, R. Zhang, S. Mader, J.H. White, Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 19(11), 2685\u20132695 (2005). https:\/\/doi.org\/10.1210\/me.2005-0106","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"3402_CR15","first-page":"181","volume":"11","author":"J Okabe-Kado","year":"1991","unstructured":"J. Okabe-Kado, Y. Honma, M. Hayashi, M. Hozumi, Effects of transforming growth factor-beta and activin A on vitamin D3-induced monocytic differentiation of myeloid leukemia cells. Anticancer Res. 11(1), 181\u2013186 (1991)","journal-title":"Anticancer Res."},{"issue":"2","key":"3402_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1006\/abbi.1997.0152","volume":"343","author":"T Nagasaki","year":"1997","unstructured":"T. Nagasaki, M. Hino, M. Inaba, Y. Nishizawa, H. Morii, S. Otani, Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells. Arch. Biochem Biophys. 343(2), 181\u2013187 (1997). https:\/\/doi.org\/10.1006\/abbi.1997.0152","journal-title":"Arch. Biochem Biophys."},{"issue":"11","key":"3402_CR17","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/jcp.24388","volume":"228","author":"VJ Woeckel","year":"2013","unstructured":"V.J. Woeckel, B.C. van der Eerden, M. Schreuders-Koedam, M. Eijken, J.P. Van Leeuwen, 1\u03b1,25-dihydroxyvitamin D3 stimulates activin A production to fine-tune osteoblast-induced mineralization. J. Cell Physiol. 228(11), 2167\u20132174 (2013). https:\/\/doi.org\/10.1002\/jcp.24388","journal-title":"J. Cell Physiol."},{"key":"3402_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bone.2015.04.038","volume":"78","author":"J Nam","year":"2015","unstructured":"J. Nam, P. Perera, R. Gordon, Y.H. Jeong, A.D. Blazek, D.G. Kim, B.C. Tee, Z. Sun, T.D. Eubank, Y. Zhao, B. Lablebecioglu, S. Liu, A. Litsky, N.L. Weisleder, B.S. Lee, T. Butterfield, A.L. Schneyer, S. Agarwal, Follistatin-like 3 is a mediator of exercise-driven bone formation and strengthening. Bone 78, 62\u201370 (2015). https:\/\/doi.org\/10.1016\/j.bone.2015.04.038","journal-title":"Bone"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03402-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03402-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03402-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T06:14:49Z","timestamp":1691129689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03402-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["3402"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03402-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"C.S.M. is a consultant of Ansh Laboratories. A.K. and B.K. are Ansh Laboratories employees. A.D.A., S.A.P, M.S., D.A.A., A.S. and P.M. have no conflict of interest in relation to the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}